Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7771538 | Bioorganic Chemistry | 2018 | 11 Pages |
Abstract
Three series of bitobic arylpiperazine-phenyl-hexahydropyrazinoquino- lines analogues were designed, synthesizedand evaluated as a novel class of selective ligands for the dopamine D3 receptor. Compounds 15a (Ki of 11.7â¯Â±â¯1.8 and 373â¯nM at D3 and D2, respectively), 15c (Ki of 5.49 and 264â¯nM at D3 and D2, respectively), 15e (Ki of 14.9 and 325â¯nM at D3 and D2, respectively), 15i (Ki of 13.8 and 401â¯nM at D3 and D2, respectively) and 15l (Ki of 13.6 and 870â¯nM at D3 and D2, respectively) were found to demonstrate good binding affinity and selectivity, and especially compound 15c showeda similar binding affinity and selectivity compared with the contrast drug BP897.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Benhua Zhou, Min Ji, Jin Cai,